Education
About Us
Working with TipRanks
Follow Us
BioVie (BIVI)
NASDAQ:BIVI
Total Valuation
BioVie has a market cap or net worth of $22.10M. The enterprise value is $59.98M.
Market Cap$22.10M
Enterprise Value$59.98M
Share Statistics
BioVie has 18,570,726 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding18,570,726
Owned by Insiders9.31%
Owned by Institutions0.39%
Financial Efficiency
BioVie’s return on equity (ROE) is -2.07 and return on invested capital (ROIC) is -148.86%.
Return on Equity (ROE)-2.07
Return on Assets (ROA)-1.27
Return on Invested Capital (ROIC)-148.86%
Return on Capital Employed (ROCE)-2.03
Revenue Per Employee0.00
Profits Per Employee-2.29M
Employee Count14
Asset Turnover0.00
Inventory Turnover0.00
Valuation Ratios
The current PE Ratio of BioVie is -1.17. BioVie’s PEG ratio is 0.35.
PE Ratio-1.17
PS Ratio0.00
PB Ratio28.31
Price to Fair Value2.43
Price to FCF-24.11
Price to Operating Cash Flow-24.11
PEG Ratio0.35
Income Statement
In the last 12 months, BioVie had revenue of 0.00 and earned -32.12M in profits. Earnings per share was -3.55.
Revenue0.00
Gross Profit-229.00K
Operating Income-32.18M
Pretax Income-32.12M
Net Income-32.12M
EBITDA-31.95M
Earnings Per Share (EPS)-3.55
Cash Flow
In the last 12 months, operating cash flow was -17.42M and capital expenditures 0.00, giving a free cash flow of -17.42M billion.
Operating Cash Flow-17.42M
Free Cash Flow-17.42M
Free Cash Flow per Share-0.94
Dividends & Yields
BioVie pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta2.01
52-Week Price Change-75.32%
50-Day Moving Average0.98
200-Day Moving Average1.80
Relative Strength Index (RSI)56.72
Average Volume (3m)664.85K
Important Dates
BioVie upcoming earnings date is May 13, 2024, TBA Not Confirmed.
Last Earnings DateFeb 14, 2024
Next Earnings DateMay 13, 2024
Ex-Dividend Date―
Financial Position
BioVie as a current ratio of 2.57, with Debt / Equity ratio of 0.00%
Current Ratio2.57
Quick Ratio2.57
Debt to Market Cap0.15
Net Debt to EBITDA0.55
Interest Coverage Ratio-11.12
Taxes
In the past 12 months, BioVie has paid 0.00 in taxes.
Income Tax0.00
Effective Tax Rate0.00
Enterprise Valuation
BioVie EV to EBITDA ratio is -0.62, with an EV/FCF ratio of -0.71.
EV to Sales0.00
EV to EBITDA-0.62
EV to Free Cash Flow-0.71
EV to Operating Cash Flow-0.71
Balance Sheet
BioVie has $23.15M in cash and marketable securities with $366.43K in debt, giving a net cash position of -$22.79M billion.
Cash & Marketable Securities$23.15M
Total Debt$366.43K
Net Cash-$22.79M
Net Cash Per Share-$1.23
Tangible Book Value Per Share$1.63
Margins
Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.
Gross Margin0.00%
Operating Margin0.00%
Pretax Margin0.00%
Net Profit Margin0.00%
EBITDA Margin0.00%
EBIT Margin0.00%
Analyst Forecast
The average price target for BioVie is $6.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$6.00
Price Target Upside426.32% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast―
EPS Growth Forecast66.72%